{"gene":"CYB5B","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2011,"finding":"CYB5B (mitochondrial cytochrome b5 type B) and MOSC2 are the essential components of the amidoxime reductase system localized exclusively to the outer mitochondrial membrane. siRNA-mediated knockdown of MOSC2 and CYB5B in differentiated 3T3-L1 adipocytes significantly inhibited amidoxime reductase activity, while knockdown of MOSC1, CYB5A, CYB5R1, CYB5R2, or CYB5R3 had no effect. Knockdown of MOSC2 also caused impaired lipid synthesis, implicating this CYB5B/MOSC2-containing system in lipogenesis at the outer mitochondrial membrane.","method":"siRNA knockdown in differentiated 3T3-L1 adipocytes, amidoxime reductase activity assay, radiolabeled substrate binding to MOSC2, subcellular fractionation of rat liver outer mitochondrial membranes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal loss-of-function with specific enzymatic readout, direct radiolabeled substrate binding, subcellular fractionation, multiple orthogonal methods in single study","pmids":["22203676"],"is_preprint":false},{"year":2013,"finding":"CYB5B (mitochondrial isoform) is an essential component of the mARC-containing N-reductase system in human cells, whereas the microsomal isoform CYB5A is not. RNAi knockdown in two human cell lines demonstrated that both mARC1 and mARC2 (MOSC1/MOSC2) reduce N-hydroxylated substrates, with extent dependent on expression level. The contribution of CYB5B to N-reductive catalysis was proven to strictly depend on heme, using heme-free apo-CYB5B. Participation of CYB5A was excluded by siRNA knockdown and knockout in mice.","method":"RNAi knockdown in HEK-293 and HepG2 cells, N-reductive biotransformation assay, heme-free apo-CYB5B reconstitution, CYB5A knockout mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (RNAi in two cell lines, knockout mouse, reconstitution with apo-protein), clear mechanistic specificity established","pmids":["23703616"],"is_preprint":false},{"year":2014,"finding":"The N-reductive system comprising mARC proteins, CYB5B, and cytochrome b5 reductase (CYB5R) is regulated by fasting and high-fat diet in mice. Fasting decreases N-reductive activity in vitro, and high-fat diet increases mARC protein levels and N-reductive activity, linking the CYB5B-containing enzyme system to energy/lipid metabolism regulation.","method":"qRT-PCR, Western blot, N-reductive biotransformation assay in mouse liver under fasting and high-fat diet conditions; in vivo benzamidoxime metabolite measurement","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (qPCR, Western blot, activity assay, in vivo pharmacokinetics) in single lab, no independent replication","pmids":["25144769"],"is_preprint":false},{"year":2017,"finding":"CYB5B forms entropy-driven complexes with CYP11A1 as measured by Surface Plasmon Resonance, in contrast to CYB5A which forms enthalpy-driven complexes with microsomal CYPs (CYP3A4, CYP3A5, CYP17A1) that are allosterically regulated. The CYB5B–CYP11A1 interaction is entropy-driven with positive ΔH, indicating no allosteric regulation of CYP11A1 activity by CYB5B.","method":"Surface Plasmon Resonance (Biacore 3000) thermodynamic analysis of 18 CYB5-CYP pairs","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous biophysical method (SPR) but single lab, no mutagenesis or functional validation of the CYB5B-CYP11A1 interaction","pmids":["28238672"],"is_preprint":false},{"year":2024,"finding":"CYB5B (mitochondrial) and CYB5A (microsomal) compensate for each other in sterol-C4 oxidation during cholesterol biosynthesis. Knockout of CYB5B alone in HeLa cells blocks cholesterol biosynthesis at the sterol-C4 oxidation step, causing accumulation of T-MAS and dihydro-T-MAS. Liver-specific Cyb5b knockout mice show normal cholesterol metabolism, but combined knockdown of Cyb5a in L-Cyb5b-/- mice causes marked accumulation of T-MAS and dihydro-T-MAS, demonstrating functional redundancy. The accumulated T-MAS and dihydro-T-MAS inhibit the SREBP pathway and activate the PPARγ pathway.","method":"CYB5B knockout in HeLa cells, liver-specific Cyb5b knockout mice, shRNA knockdown of Cyb5a in knockout mice, sterol metabolite measurement, SREBP and PPARγ pathway analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (cell KO, tissue-specific mouse KO, combined KO/KD), metabolite readout, pathway analysis; orthogonal methods in single study","pmids":["39489939"],"is_preprint":false},{"year":2011,"finding":"CYB5B is localized to the outer mitochondrial membrane, as demonstrated by its use as an outer mitochondrial membrane marker for immunomagnetic affinity enrichment of mitochondria. Anti-CYB5B antibody-coated magnetic beads efficiently enriched intact, functional mitochondria from as few as 10,000 cultured cells across multiple mouse tissues and cell lines.","method":"Subcellular fractionation, immunomagnetic affinity enrichment with anti-CYB5B antibody-coated magnetic beads, Western blot validation across multiple tissues and cell lines","journal":"Analytical biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional consequence (mitochondria isolation), validated across multiple tissues, single lab","pmids":["22178913"],"is_preprint":false},{"year":2023,"finding":"CYB5B interacts with Mitoregulin (MTLN) at the outer mitochondrial membrane, as part of an MTLN protein complex that also includes CPT1B. Loss of MTLN causes accumulation of very long-chain fatty acids, placing CYB5B in a fatty acid metabolism complex at the outer mitochondrial membrane.","method":"Split GFP-based topology reporters for submitochondrial localization, co-immunoprecipitation/interaction studies, MTLN knockout mouse model, VLCFA metabolite measurement","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — interaction with MTLN shown by pulldown/co-IP in context of multiple orthogonal localization methods, single lab","pmids":["37664623"],"is_preprint":false},{"year":2024,"finding":"CYB5B expression is reduced by LPS in human periodontal ligament fibroblasts (hPDLFs), and altered MTCH2 expression directly affects CYB5B expression. CYB5B appears to act as a downstream effector of MTCH2, with reduced CYB5B associated with increased inflammatory cytokine release and NF-κB nuclear translocation. Benzylurea treatment restored CYB5B levels and improved mitochondrial function.","method":"LPS-induced inflammation model in hPDLFs, Western blot for MTCH2 and CYB5B, measurement of mitochondrial membrane potential, mPTP, ROS, NF-κB translocation, cytokine release","journal":"Oral diseases","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single cell model, correlative relationship between MTCH2 and CYB5B expression without direct mechanistic dissection of CYB5B function","pmids":["39491029"],"is_preprint":false}],"current_model":"CYB5B is a heme-containing cytochrome b5 isoform localized exclusively to the outer mitochondrial membrane, where it functions as an essential electron transfer component of the mARC/MOSC-containing N-reductase system (reducing N-hydroxylated compounds including amidoxime prodrugs in partnership with MOSC2 and a CYB5B reductase), participates redundantly with microsomal CYB5A in sterol-C4 oxidation during cholesterol biosynthesis, interacts with fatty acid metabolism proteins including MTLN and CPT1B, and is regulated by fasting and high-fat diet — with its N-reductive activity strictly dependent on heme cofactor."},"narrative":{"mechanistic_narrative":"CYB5B is a heme-dependent cytochrome b5 isoform anchored in the outer mitochondrial membrane that supplies electrons to multiple metabolic oxidoreductase systems [PMID:22203676, PMID:22178913]. It is an essential, heme-dependent electron-transfer component of the mitochondrial mARC/MOSC N-reductase system, where—together with mARC1/mARC2 (MOSC1/MOSC2)—it reduces N-hydroxylated substrates; this role is specific to the mitochondrial CYB5B isoform and is not fulfilled by microsomal CYB5A, and is abolished when heme-free apo-CYB5B is substituted [PMID:22203676, PMID:23703616]. Beyond N-reduction, CYB5B acts redundantly with CYB5A in sterol-C4 oxidation during cholesterol biosynthesis: loss of CYB5B blocks this step and causes accumulation of T-MAS and dihydro-T-MAS, which in turn inhibits the SREBP pathway and activates PPARγ signaling [PMID:39489939]. CYB5B physically associates with fatty-acid metabolism machinery, interacting with Mitoregulin (MTLN) in a complex that also includes CPT1B at the outer mitochondrial membrane [PMID:37664623], and its enzyme system is metabolically responsive, with N-reductive activity modulated by fasting and high-fat diet [PMID:25144769]. It also forms an entropy-driven complex with the mitochondrial cytochrome P450 CYP11A1 [PMID:28238672].","teleology":[{"year":2011,"claim":"Established which cytochrome b5 isoform and partner drive the amidoxime/N-reductase activity, resolving that this is a mitochondrial outer-membrane system rather than a microsomal one.","evidence":"siRNA knockdown of candidate components in differentiated 3T3-L1 adipocytes with amidoxime reductase activity assay and radiolabeled substrate binding to MOSC2","pmids":["22203676"],"confidence":"High","gaps":["Identity of the CYB5B reductase partner not defined","Mechanism linking the system to impaired lipid synthesis not dissected"]},{"year":2011,"claim":"Confirmed CYB5B's outer mitochondrial membrane localization by exploiting it as a surface marker for intact mitochondrial isolation.","evidence":"Immunomagnetic enrichment with anti-CYB5B antibody beads and Western blot validation across multiple mouse tissues and cell lines","pmids":["22178913"],"confidence":"Medium","gaps":["Membrane topology and orientation not resolved here","Single-lab study"]},{"year":2013,"claim":"Showed the N-reductive function is strictly isoform-specific (CYB5B not CYB5A) and absolutely dependent on the heme cofactor, defining the catalytic requirement.","evidence":"RNAi in HEK-293 and HepG2 cells, N-reductive biotransformation assays, heme-free apo-CYB5B reconstitution, and CYB5A knockout mice","pmids":["23703616"],"confidence":"High","gaps":["Structural basis of electron transfer to mARC not resolved","Physiological endogenous substrates beyond xenobiotic N-hydroxy compounds unclear"]},{"year":2014,"claim":"Linked the CYB5B/mARC N-reductase system to whole-body energy state, showing it is nutritionally regulated.","evidence":"qRT-PCR, Western blot, and N-reductive activity assays in mouse liver under fasting and high-fat diet, with in vivo benzamidoxime metabolite measurement","pmids":["25144769"],"confidence":"Medium","gaps":["Regulation measured at mARC level, not directly at CYB5B","No independent replication","Mechanism of dietary regulation unknown"]},{"year":2017,"claim":"Distinguished CYB5B's interaction mode with cytochrome P450 partners, showing it forms an entropy-driven, non-allosteric complex with mitochondrial CYP11A1 unlike microsomal CYB5A-CYP complexes.","evidence":"Surface Plasmon Resonance thermodynamic analysis of 18 CYB5-CYP pairs","pmids":["28238672"],"confidence":"Medium","gaps":["No mutagenesis or functional validation of the CYB5B-CYP11A1 interaction","Functional consequence for steroidogenesis untested"]},{"year":2023,"claim":"Placed CYB5B in a defined fatty-acid metabolism complex by identifying its physical association with MTLN and CPT1B at the outer mitochondrial membrane.","evidence":"Split-GFP topology reporters, co-immunoprecipitation, MTLN knockout mouse, and VLCFA metabolite measurement","pmids":["37664623"],"confidence":"Medium","gaps":["Direct catalytic role of CYB5B in the MTLN complex not defined","Reciprocal interaction validation limited","Single lab"]},{"year":2024,"claim":"Revealed a second, distinct biosynthetic role: CYB5B supplies electrons for sterol-C4 oxidation in cholesterol biosynthesis, acting redundantly with CYB5A and impacting SREBP/PPARγ signaling.","evidence":"CYB5B knockout HeLa cells, liver-specific Cyb5b knockout mice with combined Cyb5a knockdown, sterol metabolite profiling, and SREBP/PPARγ pathway analysis","pmids":["39489939"],"confidence":"High","gaps":["Mechanism of redundancy/compensation between mitochondrial CYB5B and microsomal CYB5A unclear","Direct electron acceptor in C4 oxidation not specified"]},{"year":2024,"claim":"Correlated CYB5B with mitochondrial function and inflammatory signaling downstream of MTCH2 in an inflammation model.","evidence":"LPS-induced inflammation in periodontal ligament fibroblasts with Western blot, mitochondrial function readouts, and NF-κB/cytokine measurements","pmids":["39491029"],"confidence":"Low","gaps":["Correlative MTCH2-CYB5B relationship without direct mechanistic dissection","Single cell model, single lab","Causal role of CYB5B in inflammation not established"]},{"year":null,"claim":"The identity of the CYB5B-specific reductase that re-reduces its heme within each enzyme system, and the structural basis for partitioning between N-reduction, sterol oxidation, and fatty-acid complexes, remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of CYB5B with mARC, CYP11A1, or MTLN complexes","Reductase partner of CYB5B not definitively assigned","Determinants of substrate/pathway selectivity unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,4]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,5,6]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,4,2]},{"term_id":"R-HSA-9748784","term_label":"Drug ADME","supporting_discovery_ids":[0,1]}],"complexes":["mARC/MOSC N-reductase system","MTLN-CPT1B outer mitochondrial membrane complex"],"partners":["MOSC2","MOSC1","MTLN","CPT1B","CYP11A1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O43169","full_name":"Cytochrome b5 type B","aliases":["Cytochrome b5 outer mitochondrial membrane isoform"],"length_aa":150,"mass_kda":16.7,"function":"Cytochrome b5 is a membrane-bound hemoprotein functioning as an electron carrier for several membrane-bound oxygenases","subcellular_location":"Mitochondrion outer membrane","url":"https://www.uniprot.org/uniprotkb/O43169/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CYB5B","classification":"Not Classified","n_dependent_lines":324,"n_total_lines":1208,"dependency_fraction":0.2682119205298013},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"RTN4","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/search/CYB5B","total_profiled":1310},"omim":[{"mim_id":"611964","title":"CYTOCHROME b5, TYPE B (OUTER MITOCHONDRIAL MEMBRANE); CYB5B","url":"https://www.omim.org/entry/611964"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Endoplasmic reticulum","reliability":"Approved"},{"location":"Centriolar satellite","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"adrenal gland","ntpm":190.3}],"url":"https://www.proteinatlas.org/search/CYB5B"},"hgnc":{"alias_symbol":["CYB5-M"],"prev_symbol":[]},"alphafold":{"accession":"O43169","domains":[{"cath_id":"3.10.120.10","chopping":"23-104","consensus_level":"medium","plddt":94.5428,"start":23,"end":104},{"cath_id":"1.20.5","chopping":"121-150","consensus_level":"medium","plddt":80.2373,"start":121,"end":150}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43169","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43169-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43169-F1-predicted_aligned_error_v6.png","plddt_mean":80.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CYB5B","jax_strain_url":"https://www.jax.org/strain/search?query=CYB5B"},"sequence":{"accession":"O43169","fasta_url":"https://rest.uniprot.org/uniprotkb/O43169.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43169/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43169"}},"corpus_meta":[{"pmid":"23505434","id":"PMC_23505434","title":"Pemphigus vulgaris autoantibody profiling by proteomic technique.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23505434","citation_count":81,"is_preprint":false},{"pmid":"26496030","id":"PMC_26496030","title":"Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26496030","citation_count":69,"is_preprint":false},{"pmid":"22203676","id":"PMC_22203676","title":"Amidoxime reductase system containing cytochrome b5 type B (CYB5B) and MOSC2 is of importance for lipid synthesis in adipocyte mitochondria.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22203676","citation_count":51,"is_preprint":false},{"pmid":"25189868","id":"PMC_25189868","title":"Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study.","date":"2014","source":"American journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/25189868","citation_count":50,"is_preprint":false},{"pmid":"21878944","id":"PMC_21878944","title":"Proteomic analysis of mitochondria in APOE transgenic mice and in response to an ischemic challenge.","date":"2011","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21878944","citation_count":45,"is_preprint":false},{"pmid":"23703616","id":"PMC_23703616","title":"The involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5 in N-reductive metabolism in human cells.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23703616","citation_count":42,"is_preprint":false},{"pmid":"21456071","id":"PMC_21456071","title":"Effect of luteinizing hormone on the steroidogenic pathway in prostate cancer.","date":"2010","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/21456071","citation_count":26,"is_preprint":false},{"pmid":"21349918","id":"PMC_21349918","title":"A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21349918","citation_count":24,"is_preprint":false},{"pmid":"25144769","id":"PMC_25144769","title":"The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25144769","citation_count":23,"is_preprint":false},{"pmid":"20100355","id":"PMC_20100355","title":"Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).","date":"2010","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20100355","citation_count":19,"is_preprint":false},{"pmid":"37664623","id":"PMC_37664623","title":"LINC00116-encoded microprotein mitoregulin regulates fatty acid metabolism at the mitochondrial outer membrane.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37664623","citation_count":19,"is_preprint":false},{"pmid":"36704337","id":"PMC_36704337","title":"Whole-genome resequencing reveals genetic diversity, differentiation, and selection signatures of yak breeds/populations in Qinghai, China.","date":"2023","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36704337","citation_count":19,"is_preprint":false},{"pmid":"28238672","id":"PMC_28238672","title":"Thermodynamics of interactions between mammalian cytochromes P450 and b5.","date":"2017","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/28238672","citation_count":16,"is_preprint":false},{"pmid":"23284715","id":"PMC_23284715","title":"Brain transcriptome-wide screen for HIV-1 Nef protein interaction partners reveals various membrane-associated proteins.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23284715","citation_count":16,"is_preprint":false},{"pmid":"39472682","id":"PMC_39472682","title":"Alteration of the metabolite interconversion enzyme in sperm and Sertoli cell of non-obstructive azoospermia: a microarray data and in-silico analysis.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39472682","citation_count":12,"is_preprint":false},{"pmid":"32733541","id":"PMC_32733541","title":"Quantitative Proteomic Profiling of Mitochondrial Toxicants in a Human Cardiomyocyte Cell Line.","date":"2020","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32733541","citation_count":11,"is_preprint":false},{"pmid":"39489939","id":"PMC_39489939","title":"Defects in CYB5A and CYB5B impact sterol-C4 oxidation in cholesterol biosynthesis and demonstrate regulatory roles of dimethyl sterols.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/39489939","citation_count":8,"is_preprint":false},{"pmid":"22178913","id":"PMC_22178913","title":"A micropreparation of mitochondria from cells using magnetic beads with immunoaffinity.","date":"2011","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22178913","citation_count":7,"is_preprint":false},{"pmid":"39020437","id":"PMC_39020437","title":"Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study.","date":"2024","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/39020437","citation_count":6,"is_preprint":false},{"pmid":"38286121","id":"PMC_38286121","title":"Pain/Stress, Mitochondrial Dysfunction, and Neurodevelopment in Preterm Infants.","date":"2024","source":"Developmental neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/38286121","citation_count":5,"is_preprint":false},{"pmid":"39076954","id":"PMC_39076954","title":"Metformin Therapeutic Targets for Aortic Aneurysms: A Mendelian Randomization and Colocalization Study.","date":"2024","source":"Reviews in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39076954","citation_count":4,"is_preprint":false},{"pmid":"39538254","id":"PMC_39538254","title":"MicroRNAome profiling of breast cancer unveils hsa-miR-5683 as a tumor suppressor microRNA predicting favorable clinical outcome.","date":"2024","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/39538254","citation_count":4,"is_preprint":false},{"pmid":"32927708","id":"PMC_32927708","title":"Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism.","date":"2020","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/32927708","citation_count":3,"is_preprint":false},{"pmid":"38460853","id":"PMC_38460853","title":"Actinomycetota, a central constituent microbe during long-term exposure to diazinon, an organophosphorus insecticide.","date":"2024","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/38460853","citation_count":3,"is_preprint":false},{"pmid":"39491029","id":"PMC_39491029","title":"Benzylurea Protects hPDLFs Against LPS-Induced Mitochondrial Dysfunction Through MTCH2.","date":"2024","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/39491029","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16775,"output_tokens":2554,"usd":0.044318,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9711,"output_tokens":2963,"usd":0.061315,"stage2_stop_reason":"end_turn"},"total_usd":0.105633,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"CYB5B (mitochondrial cytochrome b5 type B) and MOSC2 are the essential components of the amidoxime reductase system localized exclusively to the outer mitochondrial membrane. siRNA-mediated knockdown of MOSC2 and CYB5B in differentiated 3T3-L1 adipocytes significantly inhibited amidoxime reductase activity, while knockdown of MOSC1, CYB5A, CYB5R1, CYB5R2, or CYB5R3 had no effect. Knockdown of MOSC2 also caused impaired lipid synthesis, implicating this CYB5B/MOSC2-containing system in lipogenesis at the outer mitochondrial membrane.\",\n      \"method\": \"siRNA knockdown in differentiated 3T3-L1 adipocytes, amidoxime reductase activity assay, radiolabeled substrate binding to MOSC2, subcellular fractionation of rat liver outer mitochondrial membranes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal loss-of-function with specific enzymatic readout, direct radiolabeled substrate binding, subcellular fractionation, multiple orthogonal methods in single study\",\n      \"pmids\": [\"22203676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CYB5B (mitochondrial isoform) is an essential component of the mARC-containing N-reductase system in human cells, whereas the microsomal isoform CYB5A is not. RNAi knockdown in two human cell lines demonstrated that both mARC1 and mARC2 (MOSC1/MOSC2) reduce N-hydroxylated substrates, with extent dependent on expression level. The contribution of CYB5B to N-reductive catalysis was proven to strictly depend on heme, using heme-free apo-CYB5B. Participation of CYB5A was excluded by siRNA knockdown and knockout in mice.\",\n      \"method\": \"RNAi knockdown in HEK-293 and HepG2 cells, N-reductive biotransformation assay, heme-free apo-CYB5B reconstitution, CYB5A knockout mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (RNAi in two cell lines, knockout mouse, reconstitution with apo-protein), clear mechanistic specificity established\",\n      \"pmids\": [\"23703616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The N-reductive system comprising mARC proteins, CYB5B, and cytochrome b5 reductase (CYB5R) is regulated by fasting and high-fat diet in mice. Fasting decreases N-reductive activity in vitro, and high-fat diet increases mARC protein levels and N-reductive activity, linking the CYB5B-containing enzyme system to energy/lipid metabolism regulation.\",\n      \"method\": \"qRT-PCR, Western blot, N-reductive biotransformation assay in mouse liver under fasting and high-fat diet conditions; in vivo benzamidoxime metabolite measurement\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (qPCR, Western blot, activity assay, in vivo pharmacokinetics) in single lab, no independent replication\",\n      \"pmids\": [\"25144769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CYB5B forms entropy-driven complexes with CYP11A1 as measured by Surface Plasmon Resonance, in contrast to CYB5A which forms enthalpy-driven complexes with microsomal CYPs (CYP3A4, CYP3A5, CYP17A1) that are allosterically regulated. The CYB5B–CYP11A1 interaction is entropy-driven with positive ΔH, indicating no allosteric regulation of CYP11A1 activity by CYB5B.\",\n      \"method\": \"Surface Plasmon Resonance (Biacore 3000) thermodynamic analysis of 18 CYB5-CYP pairs\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous biophysical method (SPR) but single lab, no mutagenesis or functional validation of the CYB5B-CYP11A1 interaction\",\n      \"pmids\": [\"28238672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CYB5B (mitochondrial) and CYB5A (microsomal) compensate for each other in sterol-C4 oxidation during cholesterol biosynthesis. Knockout of CYB5B alone in HeLa cells blocks cholesterol biosynthesis at the sterol-C4 oxidation step, causing accumulation of T-MAS and dihydro-T-MAS. Liver-specific Cyb5b knockout mice show normal cholesterol metabolism, but combined knockdown of Cyb5a in L-Cyb5b-/- mice causes marked accumulation of T-MAS and dihydro-T-MAS, demonstrating functional redundancy. The accumulated T-MAS and dihydro-T-MAS inhibit the SREBP pathway and activate the PPARγ pathway.\",\n      \"method\": \"CYB5B knockout in HeLa cells, liver-specific Cyb5b knockout mice, shRNA knockdown of Cyb5a in knockout mice, sterol metabolite measurement, SREBP and PPARγ pathway analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (cell KO, tissue-specific mouse KO, combined KO/KD), metabolite readout, pathway analysis; orthogonal methods in single study\",\n      \"pmids\": [\"39489939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CYB5B is localized to the outer mitochondrial membrane, as demonstrated by its use as an outer mitochondrial membrane marker for immunomagnetic affinity enrichment of mitochondria. Anti-CYB5B antibody-coated magnetic beads efficiently enriched intact, functional mitochondria from as few as 10,000 cultured cells across multiple mouse tissues and cell lines.\",\n      \"method\": \"Subcellular fractionation, immunomagnetic affinity enrichment with anti-CYB5B antibody-coated magnetic beads, Western blot validation across multiple tissues and cell lines\",\n      \"journal\": \"Analytical biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional consequence (mitochondria isolation), validated across multiple tissues, single lab\",\n      \"pmids\": [\"22178913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CYB5B interacts with Mitoregulin (MTLN) at the outer mitochondrial membrane, as part of an MTLN protein complex that also includes CPT1B. Loss of MTLN causes accumulation of very long-chain fatty acids, placing CYB5B in a fatty acid metabolism complex at the outer mitochondrial membrane.\",\n      \"method\": \"Split GFP-based topology reporters for submitochondrial localization, co-immunoprecipitation/interaction studies, MTLN knockout mouse model, VLCFA metabolite measurement\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — interaction with MTLN shown by pulldown/co-IP in context of multiple orthogonal localization methods, single lab\",\n      \"pmids\": [\"37664623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CYB5B expression is reduced by LPS in human periodontal ligament fibroblasts (hPDLFs), and altered MTCH2 expression directly affects CYB5B expression. CYB5B appears to act as a downstream effector of MTCH2, with reduced CYB5B associated with increased inflammatory cytokine release and NF-κB nuclear translocation. Benzylurea treatment restored CYB5B levels and improved mitochondrial function.\",\n      \"method\": \"LPS-induced inflammation model in hPDLFs, Western blot for MTCH2 and CYB5B, measurement of mitochondrial membrane potential, mPTP, ROS, NF-κB translocation, cytokine release\",\n      \"journal\": \"Oral diseases\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single cell model, correlative relationship between MTCH2 and CYB5B expression without direct mechanistic dissection of CYB5B function\",\n      \"pmids\": [\"39491029\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CYB5B is a heme-containing cytochrome b5 isoform localized exclusively to the outer mitochondrial membrane, where it functions as an essential electron transfer component of the mARC/MOSC-containing N-reductase system (reducing N-hydroxylated compounds including amidoxime prodrugs in partnership with MOSC2 and a CYB5B reductase), participates redundantly with microsomal CYB5A in sterol-C4 oxidation during cholesterol biosynthesis, interacts with fatty acid metabolism proteins including MTLN and CPT1B, and is regulated by fasting and high-fat diet — with its N-reductive activity strictly dependent on heme cofactor.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CYB5B is a heme-dependent cytochrome b5 isoform anchored in the outer mitochondrial membrane that supplies electrons to multiple metabolic oxidoreductase systems [#0, #5]. It is an essential, heme-dependent electron-transfer component of the mitochondrial mARC/MOSC N-reductase system, where—together with mARC1/mARC2 (MOSC1/MOSC2)—it reduces N-hydroxylated substrates; this role is specific to the mitochondrial CYB5B isoform and is not fulfilled by microsomal CYB5A, and is abolished when heme-free apo-CYB5B is substituted [#0, #1]. Beyond N-reduction, CYB5B acts redundantly with CYB5A in sterol-C4 oxidation during cholesterol biosynthesis: loss of CYB5B blocks this step and causes accumulation of T-MAS and dihydro-T-MAS, which in turn inhibits the SREBP pathway and activates PPARγ signaling [#4]. CYB5B physically associates with fatty-acid metabolism machinery, interacting with Mitoregulin (MTLN) in a complex that also includes CPT1B at the outer mitochondrial membrane [#6], and its enzyme system is metabolically responsive, with N-reductive activity modulated by fasting and high-fat diet [#2]. It also forms an entropy-driven complex with the mitochondrial cytochrome P450 CYP11A1 [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Established which cytochrome b5 isoform and partner drive the amidoxime/N-reductase activity, resolving that this is a mitochondrial outer-membrane system rather than a microsomal one.\",\n      \"evidence\": \"siRNA knockdown of candidate components in differentiated 3T3-L1 adipocytes with amidoxime reductase activity assay and radiolabeled substrate binding to MOSC2\",\n      \"pmids\": [\"22203676\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the CYB5B reductase partner not defined\", \"Mechanism linking the system to impaired lipid synthesis not dissected\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Confirmed CYB5B's outer mitochondrial membrane localization by exploiting it as a surface marker for intact mitochondrial isolation.\",\n      \"evidence\": \"Immunomagnetic enrichment with anti-CYB5B antibody beads and Western blot validation across multiple mouse tissues and cell lines\",\n      \"pmids\": [\"22178913\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Membrane topology and orientation not resolved here\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed the N-reductive function is strictly isoform-specific (CYB5B not CYB5A) and absolutely dependent on the heme cofactor, defining the catalytic requirement.\",\n      \"evidence\": \"RNAi in HEK-293 and HepG2 cells, N-reductive biotransformation assays, heme-free apo-CYB5B reconstitution, and CYB5A knockout mice\",\n      \"pmids\": [\"23703616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of electron transfer to mARC not resolved\", \"Physiological endogenous substrates beyond xenobiotic N-hydroxy compounds unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked the CYB5B/mARC N-reductase system to whole-body energy state, showing it is nutritionally regulated.\",\n      \"evidence\": \"qRT-PCR, Western blot, and N-reductive activity assays in mouse liver under fasting and high-fat diet, with in vivo benzamidoxime metabolite measurement\",\n      \"pmids\": [\"25144769\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Regulation measured at mARC level, not directly at CYB5B\", \"No independent replication\", \"Mechanism of dietary regulation unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Distinguished CYB5B's interaction mode with cytochrome P450 partners, showing it forms an entropy-driven, non-allosteric complex with mitochondrial CYP11A1 unlike microsomal CYB5A-CYP complexes.\",\n      \"evidence\": \"Surface Plasmon Resonance thermodynamic analysis of 18 CYB5-CYP pairs\",\n      \"pmids\": [\"28238672\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No mutagenesis or functional validation of the CYB5B-CYP11A1 interaction\", \"Functional consequence for steroidogenesis untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Placed CYB5B in a defined fatty-acid metabolism complex by identifying its physical association with MTLN and CPT1B at the outer mitochondrial membrane.\",\n      \"evidence\": \"Split-GFP topology reporters, co-immunoprecipitation, MTLN knockout mouse, and VLCFA metabolite measurement\",\n      \"pmids\": [\"37664623\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct catalytic role of CYB5B in the MTLN complex not defined\", \"Reciprocal interaction validation limited\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed a second, distinct biosynthetic role: CYB5B supplies electrons for sterol-C4 oxidation in cholesterol biosynthesis, acting redundantly with CYB5A and impacting SREBP/PPARγ signaling.\",\n      \"evidence\": \"CYB5B knockout HeLa cells, liver-specific Cyb5b knockout mice with combined Cyb5a knockdown, sterol metabolite profiling, and SREBP/PPARγ pathway analysis\",\n      \"pmids\": [\"39489939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of redundancy/compensation between mitochondrial CYB5B and microsomal CYB5A unclear\", \"Direct electron acceptor in C4 oxidation not specified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Correlated CYB5B with mitochondrial function and inflammatory signaling downstream of MTCH2 in an inflammation model.\",\n      \"evidence\": \"LPS-induced inflammation in periodontal ligament fibroblasts with Western blot, mitochondrial function readouts, and NF-κB/cytokine measurements\",\n      \"pmids\": [\"39491029\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Correlative MTCH2-CYB5B relationship without direct mechanistic dissection\", \"Single cell model, single lab\", \"Causal role of CYB5B in inflammation not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the CYB5B-specific reductase that re-reduces its heme within each enzyme system, and the structural basis for partitioning between N-reduction, sterol oxidation, and fatty-acid complexes, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of CYB5B with mARC, CYP11A1, or MTLN complexes\", \"Reductase partner of CYB5B not definitively assigned\", \"Determinants of substrate/pathway selectivity unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 4, 2]},\n      {\"term_id\": \"R-HSA-9748784\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\n      \"mARC/MOSC N-reductase system\",\n      \"MTLN-CPT1B outer mitochondrial membrane complex\"\n    ],\n    \"partners\": [\n      \"MOSC2\",\n      \"MOSC1\",\n      \"MTLN\",\n      \"CPT1B\",\n      \"CYP11A1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}